Early detection of psychosis (FePsy)
The FePsy Study aimed to screen participants and assess their risk of psychosis. A total of 234 individuals were screened, of which 91 were already psychotic, 106 were identified as individuals at-risk, and 37 were found to be at no increased risk of psychosis. The study planned to follow the participants for a minimum of 5 years at varying intervals, depending on psychosis-risk. Of the individuals at-risk, 41.4% were female and the mean age was 26.8 years. Among the first-episode patients, 27.8% were female and their mean age was 31.1 years.
Study design
Cohort - clinical
Number of participants at first data collection
234 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2000
Primary Institutions
University Hospital Basel
University of Basel (Universität Basel)
Links
Profile paper DOI
Funders
AstraZeneca AG
Bristol-Myers Squibb (BMS)
Eli Lilly SA
Janssen-Cilag AG
Nora van Meeuwen-Haefliger Stiftung
Ongoing?
No
Data types collected
- Self-report questionnaire – unspecified
- None
- Magnetic Resonance Imaging (MRI)
- None
Engagement
Keywords
